Chief Commercial Officer · EXOZYMES INC. · Common Stock
Side
M
Value
—
Shares
3,922
Price
—
Executed
Oct 9, 2026
Disclosed
Oct 26, 2026
Disclosure timeline17 days from execution to publication · legal deadline 2 business days
Oct 9 executedOct 26, 2026 disclosed
EXOZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 13.8% of prior position
Filing timing+10 / 15
Disclosed 11 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Perriman Damien Alan filed this Form 4 reporting a option exercise of EXOZ on Oct 9, 2026. It became public on Oct 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Perriman Damien Alancik:0002096714
Issuer
EXOZYMES INC.cik:0002010788
Revision history · 0
No field has changed since this record was first ingested.
